Children with medical complexity and Medicaid: spending and cost savings

Jay G Berry1, Matt Hall2, John Neff3

  • 1Jay G. Berry (jay.berry@childrens.harvard.edu) is an assistant professor of pediatrics in the Department of Medicine and Division of General Pediatrics, Boston Children's Hospital and Harvard Medical School, in Massachusetts.

Insights

Children with medical complexity covered by Medicaid drive high pediatric healthcare costs, primarily from hospitalizations. Investing in outpatient and community care can reduce these expenses and improve outcomes.

Area of Science:

  • Pediatric Health Economics
  • Healthcare Management
  • Public Health Policy

Background:

  • Children with medical complexity represent a growing population with significant healthcare needs.
  • Medicaid covers a substantial portion of these children, influencing pediatric healthcare spending.
  • Current spending patterns show a disproportionate allocation towards hospital care.

Purpose of the Study:

  • To analyze healthcare expenditures for children with medical complexity insured by Medicaid.
  • To identify potential cost savings through shifts in care delivery.
  • To propose reinvestment strategies for enhanced outpatient and community-based services.

Main Methods:

  • Expenditure analysis across the care continuum for Medicaid-enrolled children with medical complexity.
  • Development of a business case modeling cost savings from reduced hospital and emergency department utilization.
  • Estimation of potential investments in alternative care settings.

Main Results:

  • High proportion of pediatric healthcare spending is attributed to children with medical complexity on Medicaid.
  • Spending is heavily concentrated in hospital care, with less investment in primary and home care.
  • Reductions in hospital and emergency department use can generate cost savings.

Conclusions:

  • Shifting resources from acute care to outpatient and community-based services can be cost-effective.
  • These findings have implications for Medicaid quality of care and ongoing healthcare reform efforts.
  • Strategic investment in non-hospital settings can improve care for children with medical complexity.

Related Concept Videos

Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
1.1K
Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
4.3K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
373
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
392
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
935
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
895